Skip to main navigation Skip to search Skip to main content

Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence

  • Hisashi Saji
  • , Masahiro Tsuboi
  • , Yoshihisa Shimada
  • , Yasufumi Kato
  • , Wakako Hamanaka
  • , Yujin Kudo
  • , Koichi Yoshida
  • , Jun Matsubayashi
  • , Jitsuo Usuda
  • , Tatsuo Ohira
  • , Norihiko Ikeda

Research output: Contribution to journal › Article › peer-review

Abstract

Clinicohistopathological staging is insufficient to predict disease progression and clinical outcome in lung carcinoma. Based on the results of the principal component analysis of 24 samples of early-stage lung adenocarcinoma, two subgroups were identified within the early-relapse group. The histological classification of all samples of group A was poorly differentiated, whereas one out of three in group B was poorly differentiated. DAVID functional annotation analysis revealed that the molecular pathways enriched in group A included those associated with cell adhesion molecules (CAMs), cell cycle and antigen processing and presentation, whereas those in group B included CAMs, T cell receptor signaling, cytokine-cytokine receptor interaction, toll-like receptor signaling, chemokine signaling, primary immunodeficiency and natural killer cell-mediated cytotoxicity. The CAM pathway was enriched in both groups. This comprehensive gene expression and functional pathway analysis identified a distinct molecular pathway, CAMs, that correlated with the early relapse of patients with early-stage lung adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)1902-1906
Number of pages5
JournalOncology reports
Volume29
Issue number5
DOIs
StatePublished - May 2013

Keywords

  • Cell adhesion molecule
  • Early relapse
  • Lung adenocarcinoma
  • Microarray
  • Molecular pathway analysis
  • Prognostic factor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence'. Together they form a unique fingerprint.

Cite this